Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,187 total articles
A spouse of major Ginkgo Bioworks shareholder Canton Barry sold 124,727 Class A shares on April 10, 2026, to satisfy tax withholding obligations tied to the vesting of performance-based restricted stock units. The transaction followed the April 9, 2026 vesting of 251,786 PSUs. Ginkgo reported improvements in financial management and reduced operati…
ServiceTitan Chief Accounting Officer Michele O’Connor executed a sale of 5,000 Class A shares on April 9, 2026, for $58.93 per share, netting $294,650. The transaction, disclosed in a Form 4 filed with the SEC and signed on her behalf on April 13, 2026, leaves O’Connor with 79,416.5 directly held shares. The move occurs while the stock trades clos…
Brett Alan Cope, President and CEO of Powell Industries INC (NASDAQ:POWL), sold 4,440 shares on April 9, 2026 under a Rule 10b5-1 plan, generating roughly $1.04 million. The sale occurred as the stock traded close to its 52-week high after a 302% return over the past year. Powell reported fiscal 2026 first-quarter EPS that beat estimates and announ…
Meredith Cook, Senior Vice President, General Counsel and Secretary of ANI Pharmaceuticals (ANIP), sold 500 shares on April 13, 2026, for $77.95 apiece, netting $38,975. The trade was carried out under a Rule 10b5-1 plan adopted on September 15, 2025. ANI reported fourth-quarter 2025 EPS of $2.33 and revenue of $247.1 million, both above consensus,…
Braze, Inc. general counsel Susan Wiseman sold 35,000 shares of Class A common stock on April 9, 2026, for $710,150, according to an SEC Form 4 filing. The transaction occurred as the share price has fallen sharply year-to-date; analysts have issued divergent price target changes even as firms highlighted solid bookings and revenue growth.
Exzeo Group Chief Executive Officer Paresh Patel acquired 2,000 shares of the company's common stock on April 10, 2026, paying $15.38 per share for a total of $30,760. After the trade Patel directly owns 1,608,013 shares and retains options to buy 5,000,000 additional shares under an October 1, 2021 grant. The transaction comes as Exzeo reported fo…
Guidewire Software Chief Executive Michael George Rosenbaum sold 1,200 shares on April 13, 2026, for $118.77 per share, generating $142,524. The sale was carried out automatically under a 10b5-1 plan adopted October 14, 2025. Guidewire also reported fiscal second-quarter results that exceeded expectations across revenue, annual recurring revenue (A…
Martine Rothblatt, Chairperson and CEO of United Therapeutics (UTHR), sold roughly $5.4 million of company stock on April 10, 2026, while also exercising stock options. The transactions were carried out under a 10b5-1 trading plan put in place in November 2025. The moves come as the stock trades close to its 52-week high and after a year of signifi…
Village Super Market Inc.'s CFO and Treasurer, John L. Van Orden, reported the sale of 8,000 Class A shares for $351,032 in a Form 4 filing. The company recently declared a quarterly cash dividend and continues to litigate against Wakefern Food Corp., where counterclaims and a third-party complaint have been filed.
Delta Air Lines Executive Vice President and Chief of Operations John E. Laughter sold 69,304 shares on April 10, 2026, realizing $4,722,928, and on the same day exercised options to acquire 22,540 shares valued at $1,153,861. The trades coincide with robust share performance and positive analyst commentary following Delta's first-quarter 2026 resu…
Nuvalent Chief Scientific Officer Henry E. Pelish sold 3,093 shares of Class A Common Stock on April 9, 2026, for roughly $323,164 and exercised options to acquire an equal number of shares at $27.85 each. The transactions leave him with 65,604 shares directly. The moves coincide with recent regulatory filings for two oncology candidates, a sizable…
Howard Justyn Russell, executive chair at Sprout Social Inc. (NASDAQ: SPT), sold 40,000 shares of Class A Common Stock on April 10, 2026, for $201,320, with prices between $4.935 and $5.355 as the share price hovered near its 52-week low of $4.93. On the same day he converted 40,000 Class B shares into Class A shares. The company recently reported …
Virco MFG Corporation Chief Executive Robert A. Virtue purchased 3,300 shares of the company’s common stock on April 10, 2026, at $5.52 per share for a total of $18,216. The transaction follows an 8.5% share decline over the prior week and comes as the company reported lower revenue and earnings for fiscal 2026, driven in part by the absence of rou…
Casey O'Connor, Stitch Fix's chief legal officer, sold 60,000 Class A common shares on April 10, 2026, for roughly $185,010 under a Rule 10b5-1 plan. The move follows a quarter in which Stitch Fix topped revenue and EPS expectations, resumed share repurchases and reported continued operational progress, even as the stock remains down year-to-date.
Hershey Trust Co, acting as trustee for the Milton Hershey School, sold 20,407 shares of Hershey Co common stock across April 9 and 10 for roughly $4.1 million, according to a Form 4 filing. The sales were executed in a series of trades at prices spanning $202.4527 to $210.5392. After the transactions, the trust retains both direct and indirect hol…
Belite Bio Chief Executive Officer Lin Yu-Hsin sold 9,200 American depositary shares on April 9, 2026, generating $1.66 million in proceeds through a pre-established Rule 10b5-1 trading plan. The transaction comes amid strong stock performance over the past year and ahead of a planned NDA submission to the U.S. FDA for tinlarebant following positiv…
Xencor Inc.'s senior finance executive sold 3,499 shares on April 10, 2026, to satisfy tax withholding tied to restricted stock unit vesting. The sale comes amid a royalty payment disagreement with Alexion Pharmaceuticals over U.S. sales of Ultomiris and contrasting analyst assessments that underscore execution and clinical strategy questions.
Dell Technologies Chief Financial Officer David Alan Kennedy sold 19,500 shares of Class C Common Stock on April 9, 2026, for roughly $3.5 million. The transactions took place as the stock traded close to its 52-week high, and several analysts updated coverage and price targets reflecting divergent views on memory pricing and demand for AI infrastr…
Connect Midstream, LLC and related entities purchased 1,220,918 shares of Summit Midstream Corp (NYSE: SMC) on March 31, 2026, at $31.08 per share, a transaction valued at roughly $37.9 million that increased Connect Midstream's direct holdings to 1,367,397 shares. The stock trades below the purchase price at $28.54, though it has risen 41% over th…
Twist Bioscience Corp CFO Adam Laponis sold 2,597 shares on April 9, 2026, for $49.889 per share, a transaction worth $129561. The sale, executed to satisfy tax withholding tied to restricted stock unit vesting, occurred while shares traded near $50.38 and not far from a 52-week peak. The company reported mixed fiscal first-quarter results and anno…
Datadog Chief Executive Olivier Pomel sold $4.7 million of Class A common stock on April 9, 2026 under a pre-arranged 10b5-1 plan, converting Class B shares into Class A and exercising stock options the same day. The share sales occurred amid recent price weakness and follow product launches and analyst coverage that highlight the company's exposur…
Cyril Perducat, Rockwell Automation's senior vice president and chief technology officer, sold 198 shares on April 10, 2026, for roughly $78,209. The sale occurred amid a 75% year-over-year stock rise and analyst commentary highlighting valuation concerns and mixed ratings. The company also reported option exercises by Perducat on April 9 of 581 sh…
A Semtech Corporation director sold 2,500 shares on April 9, 2026, for a total of $222,448 at a weighted average price of $88.98. The stock has continued to trade higher since the sale, reaching $91.83 and marking a 220% gain over the past year. The company recently introduced a 48V USB Power Delivery circuit protection device, reported a fiscal fo…
Director Patten Jarrod M sold 1,900 Class A shares of Strategy Inc. on April 9, 2026, realizing $248,104 at prices between $130.075 and $132.0 per share. On the same day he exercised options to acquire 1,900 additional Class A shares at $18.654 each for $35,442. After these transactions, Patten directly holds 28,000 Class A shares and several tranc…
Science Applications International Corp. (NASDAQ: SAIC) Executive Vice President Srinivas Attili acquired 100 shares on April 9, 2026, at $94.96 per share for a total of $9,496. The purchase comes after a recent 7.5% decline in the stock and follows company results that showed an adjusted diluted EPS beat alongside a slight revenue shortfall. Board…
